Table 1 World Health Organization Trial Registration Data Set
Data category | Information |
|---|---|
Primary registry and trial identifying number | Current Controlled Trials database |
Date of registration in primary registry | 23-Jul-15 |
Secondary identifying numbers | N/A |
Source(s) of monetary or material support | University of Exeter Medical School, UK |
Primary sponsor | University of Exeter, UK |
Secondary sponsor(s) | N/A |
Contact for public queries | Holly Victoria Rose Sugg |
University of Exeter Medical School, UK | |
h.v.s.sugg@exeter.ac.uk | |
Contact for scientific queries | Holly Victoria Rose Sugg |
University of Exeter Medical School, UK | |
h.v.s.sugg@exeter.ac.uk | |
Public title | The Morita Trial |
Scientific title | Morita Therapy for Depression and Anxiety: A Feasibility and Pilot Study |
Countries of recruitment | UK |
Health condition(s) or problem(s) studied | Depression |
Intervention(s) | Morita Therapy |
Treatment as usual | |
Key inclusion and exclusion criteria | Ages eligible for study: ≥18 years; |
Sexes eligible for study: both; | |
Accepts healthy volunteers: no | |
Inclusion criteria: adult patient (≥18 years), current DSM Major Depressive Disorder | |
Exclusion criteria: cognitive impairment, bipolar disorder or psychosis/psychotic symptoms, substance dependence, acute suicidal risk, current psychological therapy | |
Study type | Interventional |
Allocation: randomised intervention model | |
Primary purpose: treatment | |
Phase II | |
Date of first enrolment | Sep-15 |
Target sample size | 72 |
Recruitment status | Recruiting |
Primary outcome(s) | Depressive symptoms, generalised anxiety symptoms, quality of life, attitudes (at four-month follow-up); qualitative exploration of acceptability. |
Key secondary outcomes | N/A |